Day: September 4, 2025

Alma íbúðafélag hf. heldur lokað útboð þriðjudaginn 9. september nk. á þriggja mánaða óverðtryggðum víxlum (AL 25 1215) og sex mánaða óverðtryggðum víxlum (AL 26 0315). Víxlarnir eru óveðtryggðir. Arctica Finance hf. hefur umsjón með útboðinu og kynningu þess fyrir hugsanlegum fjárfestum. Útboðið verður með hollenskri aðferð, þ.e. öll samþykkt tilboð bjóðast fjárfestum á hæstu samþykktu flötu vöxtum. Víxlarnir eru gefnir út í 20 m.kr. nafnverðseiningum og verða teknir til viðskipta á Aðalmarkaði Nasdaq Iceland. Alma íbúðafélag hf. áskilur sér rétt til þess að taka hvaða tilboði sem er eða hafna þeim öllum. Niðurstöður útboðsins verða birtar opinberlega eigi síðar en næsta virka dag eftir útboð. Skila skal inn tilboðum á netfangið m@arctica.is fyrir klukkan 17:00 þriðjudaginn 9. september 2025. Uppgjör viðskipta fer fram 15. september...

Stockholm, September 4, 2025 – Virtune today announces that selected crypto ETPs, including for Bitcoin, Ethereum, XRP, and Solana, are now available for monthly savings. This makes it easier than ever for investors to set up a long-term, automatic, and commission-free monthly savings plan in Bitcoin and other crypto assets. The initiative is part of Virtune’s mission to make investing in crypto assets as simple as possible. By setting up a monthly savings plan, investors can automatically invest in Virtune’s ETPs long-term every month without paying any commission fees. Nordnet is the first platform to enable monthly savings in Virtune’s crypto ETPs. Benefits of monthly savings in Virtune’s ETPs now available at Nordnet:Commission-free savings in selected Virtune ETPsAutomatic monthly investingExposure to leading crypto...

VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug discovery, today announced that Executive Chairman, Jeffrey Bacha, and Chief Financial Officer, Dr. David Kideckel, will attend and present at the H.C. Wainwright 27th Annual Global Investment Conference, taking place September 8th-10th in New York City. Mr. Bacha will present an overview of Rakovina’s research and development pipeline, corporate strategy, and upcoming milestones. The presentation will be accessible to registered conference attendees, with a recording made available on Rakovina’s website and social media channels following the event. Throughout the conference, management will also participate...

PRESS RELEASE                                         Share Buyback Transaction Details August 28 – September 3, 2025 Alphen aan den Rijn – September 4, 2025 – Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 158,600 of its own ordinary shares in the period from August 28, 2025, up to and including September 3, 2025, for €17.0 million and at an average share price of €106.94. These repurchases are part of the share buyback program announced on February 26, 2025, under which we intend to repurchase shares for up to € 1 billion during 2025. The cumulative amounts repurchased in the year to date under this program are as follows: Share Buyback 2025Period Cumulative shares repurchased in period Total consideration(€ million) ...

Press Release Nokia recognized with IEEE Milestone Award for ADSL breakthrough, enabling the evolution from 1 Mbps to 100 Gbps broadbandIEEE honors Nokia with a prestigious Milestone Award for its introduction of ADSL in the 1990s, a breakthrough innovation that marked the beginning of the broadband era for 1 billion people. ADSL joins an impressive list of IEEE Milestone-recognized breakthroughs, including Maxwell’s equations, the transatlantic cable, and the Compact Disc. 30 years later, Nokia continues to lead broadband innovation with fiber broadband prototypes running at 100Gbps – up to 100,000x faster than the first 1Mbps ADSL demonstrators.4 September 2025 Espoo, Finland – Nokia today announced that IEEE, the world’s largest technical professional organization advancing technology for humanity, recognized the company for its...

TOKYO, Sept. 04, 2025 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) will present its latest test solutions at SEMICON Taiwan 2025 on Sept. 10-12 at the TaiNEX 1 & 2 in Taipei. At this year’s SEMICON Taiwan, Advantest will present innovative, sustainable test technology guided by its new corporate vision, “Be the most trusted and valued test solution company in the semiconductor value chain.” Moreover, Advantest’s Taiwanese subsidiary will commemorate its 30th anniversary, celebrating decades of service to Taiwan’s rapidly growing semiconductor market. Presentations and SponsorshipAdvantest is a proud platinum sponsor of this year’s Advanced Testing Forum, which will take place on Sept. 11 in room 701F at the Taipei Nangang Exhibition Center, Hall 2. Fabio Pizza, business...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1993, AS AMENDED (THE “SECURITIES ACT”)) OR ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE US VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT. NANTERRE (FRANCE)SEPTEMBER 4, 2025 FORVIA SUCCESSFULLY PRICES 5.5-YEAR EUR 600 MILLION SENIOR NOTES DUE 2031 FORVIA has successfully priced €600 million of 5.375% senior notes due March 2031 (the “Notes”). The initial offering of €500 million was significantly oversubscribed,...

STOCKHOLM – September 4, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has presented data showing that its drug candidate golexanolone provides sustained reversal of neuroinflammation in a Parkinson’s disease model. The data, published in the scientific journal Frontiers in Immunology, support a key mechanism for golexanolone in alleviating symptoms of Parkinson’s disease, which paves the way for the use of golexanolone as a chronic treatment. Parkinson’s disease is a progressive neurodegenerative disease hallmarked by motor symptoms and disrupted cognitive functions as well as mental health. The disorder is caused by the loss of nerve cells in the brain that produce the signaling substance dopamine, which leads to various symptoms reducing the patient’s well-being...

The Carbon Trust assures Verisk tool delivering industry-first emissions tracking for property claims London, UK, Sept. 04, 2025 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading data and analytics provider to the global insurance industry, has announced the launch of the insurance industry’s first Carbon Trust Assured Model for property claims in the UK. The new Verisk Property Claims Carbon Calculator empowers insurers to accurately measure, benchmark and strategise to reduce the carbon footprint for their claims. The innovative new tool supports compliance with Scope 3 emissions reporting and advances sustainability leadership across the sector, and Verisk is making it available to its clients and the broader market. Developed in collaboration with the Carbon Trust, the calculator is designed to meet the growing demand for...